122 related articles for article (PubMed ID: 23025843)
21. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
[TBL] [Abstract][Full Text] [Related]
22. The Food and Drug Administration gets new tools to spur regulatory science.
Norman B
Health Aff (Millwood); 2012 Sep; 31(9):1919-22. PubMed ID: 22949438
[No Abstract] [Full Text] [Related]
23. Administrative practices and procedures; internal agency review of decisions; companion document to direct final rule; correction--FDA. Proposed rule; correction.
Fed Regist; 1998 Sep; 63(184):50815. PubMed ID: 10185805
[TBL] [Abstract][Full Text] [Related]
24. Administrative practices and procedures; internal agency review of decisions--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Sep; 63(184):50757. PubMed ID: 10185804
[TBL] [Abstract][Full Text] [Related]
25. Product safety and business interests: deja vu..
Rijswijk L
Ostomy Wound Manage; 2005 Feb; 51(2):8-9. PubMed ID: 15699549
[No Abstract] [Full Text] [Related]
26. Why doctors should worry about preemption.
Curfman GD; Morrissey S; Drazen JM
N Engl J Med; 2008 Jul; 359(1):1-3. PubMed ID: 18596269
[No Abstract] [Full Text] [Related]
27. UK minister lobbied EU for lighter regulation of drugs and devices.
Cohen D
BMJ; 2016 Jun; 353():i3357. PubMed ID: 27307393
[No Abstract] [Full Text] [Related]
28. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
[TBL] [Abstract][Full Text] [Related]
29. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
O'Reilly JT
Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
[No Abstract] [Full Text] [Related]
30. Unapproved Ophthalmic Drugs.
Novack GD
Ocul Surf; 2016 Apr; 14(2):317-20. PubMed ID: 27107659
[No Abstract] [Full Text] [Related]
31. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
Burkhart CG
J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
[No Abstract] [Full Text] [Related]
32. Administrative practices and procedures; internal review of agency decisions---FDA. Direct final rule.
Fed Regist; 1998 Jun; 63(115):32733-5. PubMed ID: 10180278
[TBL] [Abstract][Full Text] [Related]
33. Change, but not in dollar bills. FDA needs more than money to fix problems: Congress.
Lubell J
Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18320666
[No Abstract] [Full Text] [Related]
34. Relocating abroad. FDA sends staff overseas to help monitor imports.
Lee J
Mod Healthc; 2011 Oct; 41(43):32. PubMed ID: 22111150
[No Abstract] [Full Text] [Related]
35. Shrinking waters in the safe harbor: has Integra Lifesciences v. Merck turned the tide by narrowing available exempted infringing uses?
Davison AM
Food Drug Law J; 2004; 59(1):79-92. PubMed ID: 15190926
[No Abstract] [Full Text] [Related]
36. Financial disclosure by clinical investigators; correction--FDA. Final rule; correction.
Fed Regist; 1998 Jun; 63(124):35134. PubMed ID: 10180634
[TBL] [Abstract][Full Text] [Related]
37. [Assessment of innovations in clinical research: strengths and potentials for improvement of research in Germany].
Vollmar HC; Georgieff P; Bührlen B
Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):738-43. PubMed ID: 21147437
[TBL] [Abstract][Full Text] [Related]
38. Mutual Recognition of the Food and Drug Administration and European Community Member State Conformity Assessment Procedures; pharmaceutical GMP inspection reports, medical device quality system evaluation reports, and certain medical device premarket evaluation reports--FDA. Proposed rule.
Fed Regist; 1998 Apr; 63(69):17744-71. PubMed ID: 10177764
[TBL] [Abstract][Full Text] [Related]
39. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
Lang L
Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
[No Abstract] [Full Text] [Related]
40. Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice.
Fed Regist; 1998 Jun; 63(113):32219-34. PubMed ID: 10180275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
